| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 2.34e-05 | 9 | 137 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 3.32e-05 | 10 | 137 | 3 | GO:1903301 | |
| GeneOntologyCellularComponent | procentriole replication complex | 5.92e-06 | 6 | 141 | 3 | GO:0120099 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.64e-05 | 8 | 141 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 3.48e-05 | 10 | 141 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.04e-04 | 14 | 141 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | procentriole | 1.35e-04 | 3 | 141 | 2 | GO:0120098 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.28e-04 | 18 | 141 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 3.15e-04 | 20 | 141 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 3.65e-04 | 21 | 141 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear membrane | 6.17e-04 | 349 | 141 | 9 | GO:0031965 | |
| GeneOntologyCellularComponent | methyltransferase complex | 8.31e-04 | 108 | 141 | 5 | GO:0034708 | |
| GeneOntologyCellularComponent | pericentriolar material | 8.70e-04 | 28 | 141 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | microtubule organizing center | LCA5 HDAC6 KNSTRN TACC2 CEP192 RABGAP1 STIL SPECC1 SPDL1 EYS CEP78 TTLL11 CEP250 CDK5RAP2 CEP152 | 1.39e-03 | 919 | 141 | 15 | GO:0005815 |
| HumanPheno | Self-injurious behavior | 1.27e-05 | 210 | 46 | 10 | HP:0100716 | |
| HumanPheno | Abnormal cerebral ventricle morphology | SOX5 FAT4 ZBTB20 HDAC6 TCOF1 KNSTRN LAMA1 RNF213 CHD7 HUWE1 STIL NSUN2 CASZ1 TGIF1 KMT2C SALL1 BRF1 HECW2 ASXL3 SCN4A CDK5RAP2 CEP152 | 2.94e-05 | 1046 | 46 | 22 | HP:0002118 |
| HumanPheno | Abnormal cartilage morphology | 6.81e-05 | 49 | 46 | 5 | HP:0002763 | |
| HumanPheno | Restricted or repetitive behaviors or interests | TLK2 SOX5 ZBTB20 GRIA2 CHD7 HUWE1 CASZ1 HECW2 ASXL3 KMT2A MACF1 CEP152 | 6.92e-05 | 368 | 46 | 12 | HP:0031432 |
| HumanPheno | Perseverative thought | TLK2 SOX5 ZBTB20 GRIA2 CHD7 HUWE1 CASZ1 HECW2 ASXL3 KMT2A MACF1 CEP152 | 8.76e-05 | 377 | 46 | 12 | HP:0030223 |
| HumanPheno | Disordered formal thought process | TLK2 SOX5 ZBTB20 GRIA2 CHD7 HUWE1 CASZ1 HECW2 ASXL3 KMT2A MACF1 CEP152 | 1.10e-04 | 386 | 46 | 12 | HP:0025769 |
| HumanPheno | Disinhibition | TLK2 SOX5 FAT4 ZBTB20 GRIA2 CHD7 HUWE1 STIL NSUN2 CASZ1 TGIF1 KMT2C BRF1 HECW2 ASXL3 KMT2A ANKRD17 CEP152 | 1.12e-04 | 807 | 46 | 18 | HP:0000734 |
| HumanPheno | Inappropriate behavior | TLK2 SOX5 FAT4 ZBTB20 GRIA2 CHD7 HUWE1 STIL NSUN2 CASZ1 TGIF1 KMT2C BRF1 HECW2 ASXL3 KMT2A ANKRD17 CEP152 | 1.12e-04 | 807 | 46 | 18 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | TLK2 SOX5 FAT4 ZBTB20 GRIA2 CHD7 HUWE1 STIL NSUN2 CASZ1 TGIF1 KMT2C BRF1 HECW2 ASXL3 KMT2A ANKRD17 CEP152 | 1.12e-04 | 807 | 46 | 18 | HP:5200123 |
| HumanPheno | Social disinhibition | TLK2 SOX5 FAT4 ZBTB20 GRIA2 CHD7 HUWE1 STIL NSUN2 CASZ1 TGIF1 KMT2C BRF1 HECW2 ASXL3 KMT2A ANKRD17 CEP152 | 1.12e-04 | 807 | 46 | 18 | HP:5200029 |
| HumanPheno | Aggressive behavior | SOX5 FAT4 ZBTB20 GRIA2 CHD7 STIL CASZ1 TGIF1 KMT2C BRF1 HECW2 ASXL3 KMT2A CEP152 | 1.13e-04 | 516 | 46 | 14 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | SOX5 FAT4 ZBTB20 GRIA2 CHD7 STIL CASZ1 TGIF1 KMT2C BRF1 HECW2 ASXL3 KMT2A CEP152 | 1.13e-04 | 516 | 46 | 14 | HP:0006919 |
| HumanPheno | Blepharophimosis | 1.33e-04 | 129 | 46 | 7 | HP:0000581 | |
| HumanPheno | Motor stereotypy | SOX5 ZBTB20 GRIA2 HUWE1 CASZ1 HECW2 ASXL3 KMT2A MACF1 CEP152 | 1.50e-04 | 280 | 46 | 10 | HP:0000733 |
| HumanPheno | Abnormal social development | TLK2 SOX5 LCA5 FAT4 ZBTB20 GRIA2 CHD7 HUWE1 STIL NSUN2 CASZ1 TGIF1 KMT2C BRF1 HECW2 ASXL3 KMT2A ANKRD17 CEP152 | 1.58e-04 | 908 | 46 | 19 | HP:0025732 |
| HumanPheno | Abnormal thought pattern | TLK2 SOX5 ZBTB20 GRIA2 CHD7 HUWE1 CASZ1 HECW2 ASXL3 KMT2A MACF1 CEP152 | 1.70e-04 | 404 | 46 | 12 | HP:5200269 |
| HumanPheno | Anal stenosis | 2.21e-04 | 34 | 46 | 4 | HP:0002025 | |
| HumanPheno | Abnormality of mouth size | TLK2 FAT4 ZBTB20 HDAC6 TCOF1 CHD7 HUWE1 NSUN2 CASZ1 SALL1 HECW2 ASXL3 | 2.75e-04 | 425 | 46 | 12 | HP:0011337 |
| HumanPheno | Inferior cerebellar vermis hypoplasia | 2.91e-04 | 15 | 46 | 3 | HP:0007068 | |
| HumanPheno | Abnormally increased volition | TLK2 SOX5 FAT4 ZBTB20 GRIA2 CHD7 HUWE1 STIL NSUN2 CASZ1 TGIF1 KMT2C BRF1 HECW2 ASXL3 KMT2A ANKRD17 CEP152 | 2.96e-04 | 869 | 46 | 18 | HP:5200263 |
| HumanPheno | Abnormality of the palpebral fissures | TLK2 SOX5 FAT4 ZBTB20 TCOF1 CHD7 HUWE1 STIL NSUN2 KMT2C SALL1 BRF1 ASXL3 SCN4A KMT2A ANKRD17 CDK5RAP2 CEP152 | 3.48e-04 | 880 | 46 | 18 | HP:0008050 |
| Domain | Ran_BP1 | 9.19e-05 | 12 | 143 | 3 | PF00638 | |
| Domain | RANBD1 | 9.19e-05 | 12 | 143 | 3 | PS50196 | |
| Domain | RanBD | 1.19e-04 | 13 | 143 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 1.19e-04 | 13 | 143 | 3 | IPR000156 | |
| Domain | BAT2_N | 1.74e-04 | 3 | 143 | 2 | PF07001 | |
| Domain | BAT2_N | 1.74e-04 | 3 | 143 | 2 | IPR009738 | |
| Domain | PRRC2 | 1.74e-04 | 3 | 143 | 2 | IPR033184 | |
| Domain | - | 2.20e-04 | 39 | 143 | 4 | 3.30.1370.10 | |
| Domain | KH_dom_type_1 | 3.53e-04 | 44 | 143 | 4 | IPR004088 | |
| Domain | LamG | 3.53e-04 | 44 | 143 | 4 | SM00282 | |
| Domain | FYrich_C | 5.73e-04 | 5 | 143 | 2 | IPR003889 | |
| Domain | FYrich_N | 5.73e-04 | 5 | 143 | 2 | IPR003888 | |
| Domain | FYRC | 5.73e-04 | 5 | 143 | 2 | SM00542 | |
| Domain | FYRN | 5.73e-04 | 5 | 143 | 2 | SM00541 | |
| Domain | FYRN | 5.73e-04 | 5 | 143 | 2 | PF05964 | |
| Domain | FYRC | 5.73e-04 | 5 | 143 | 2 | PF05965 | |
| Domain | FYRC | 5.73e-04 | 5 | 143 | 2 | PS51543 | |
| Domain | FYRN | 5.73e-04 | 5 | 143 | 2 | PS51542 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | RGPD4 RANBP2 CENPC CEP192 SPDL1 CEP78 CEP250 RGPD3 CDK5RAP2 CEP152 | 1.13e-06 | 202 | 96 | 10 | MM15362 |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 5.74e-06 | 18 | 96 | 4 | MM1549 | |
| Pathway | REACTOME_CELL_CYCLE | RGPD4 RANBP2 GINS3 CENPC RSF1 PSMD1 CEP192 SPDL1 CEP78 CEP250 RGPD3 CDK5RAP2 CEP152 TP53BP1 | 5.53e-05 | 603 | 96 | 14 | MM14635 |
| Pathway | REACTOME_M_PHASE | RGPD4 RANBP2 CENPC PSMD1 CEP192 SPDL1 CEP78 CEP250 RGPD3 CDK5RAP2 CEP152 | 6.31e-05 | 387 | 96 | 11 | MM15364 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 7.48e-05 | 204 | 96 | 8 | M4217 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 1.20e-04 | 71 | 96 | 5 | MM15495 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 1.29e-04 | 72 | 96 | 5 | M27749 | |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 2.25e-04 | 81 | 96 | 5 | M748 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 2.81e-04 | 85 | 96 | 5 | MM14906 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 3.14e-04 | 87 | 96 | 5 | M27194 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 3.67e-04 | 90 | 96 | 5 | MM14979 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 4.71e-04 | 95 | 96 | 5 | M6729 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 4.94e-04 | 96 | 96 | 5 | MM15207 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 5.18e-04 | 97 | 96 | 5 | M27478 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 5.96e-04 | 100 | 96 | 5 | MM14561 | |
| Pubmed | RGPD4 TLK2 CASC3 RANBP2 SLK TCOF1 GRIA2 CHD7 HUWE1 TTC3 RTN1 ADD1 AKAP12 SIRPG FXR1 FAM120A PRRC2C RGPD3 ANKRD17 CDK5RAP2 MACF1 SSH2 PPP6R2 TP53BP1 PRRC2B | 3.85e-13 | 963 | 147 | 25 | 28671696 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CASC3 ZBTB20 FRMPD1 RNF213 PSMD1 CEP192 RABGAP1 HUWE1 PRKRIP1 TTC3 CASZ1 CLCC1 PCDHB16 PPP4R4 ANKRD44 KMT2C CFAP20DC MRTFB FAM120A TESMIN TTLL11 OSBPL5 ZNF638 ANKRD17 MACF1 RCOR3 ZFHX3 ANKRD24 INVS | 5.01e-12 | 1489 | 147 | 29 | 28611215 |
| Pubmed | TLK2 RNMT HDAC6 FRMPD1 UTP14A AKNAD1 PSMD1 TACC2 CHD7 CEP192 HUWE1 TTC3 AKAP12 TGIF1 KMT2C FXR1 CTR9 ZNF638 ANKRD17 CDK5RAP2 MACF1 RCOR3 TMEM131 SLC29A1 TP53BP1 | 5.06e-12 | 1084 | 147 | 25 | 11544199 | |
| Pubmed | RANBP2 TCOF1 UTP14A RSF1 USP24 PSMD1 CHD7 HUWE1 NSUN2 FXR1 FAM120A PREP PRRC2C ZNF638 KMT2A ANKRD17 MACF1 TP53BP1 PRRC2B | 4.80e-11 | 653 | 147 | 19 | 22586326 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TLK2 RANBP2 HDAC6 TCOF1 USP24 TATDN2 PSMD1 CHD7 HUWE1 NSUN2 WTAP USP19 ADD1 PASK CTR9 ZNF638 KMT2A ANKRD17 ZHX1 TP53BP1 | 1.16e-10 | 774 | 147 | 20 | 15302935 |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | RGPD4 RANBP2 HSPBAP1 HUWE1 RTN1 AKAP12 PRRC2C RGPD3 ANKRD17 TP53BP1 | 1.14e-09 | 153 | 147 | 10 | 26365490 |
| Pubmed | RGPD4 RANBP2 USP24 PSMD1 CHD7 RABGAP1 HUWE1 SPDL1 MRTFB SALL1 RGPD3 ANKRD17 RCOR3 ZFHX3 | 3.31e-09 | 418 | 147 | 14 | 34709266 | |
| Pubmed | HDAC6 RSF1 SPECC1 KMT2C FAM120A CTR9 PRRC2C PAXIP1 ZNF638 KMT2A TP53BP1 | 1.11e-08 | 251 | 147 | 11 | 31076518 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | TLK2 RANBP2 SLK UTP14A SRPRA TTC3 ADD1 AKAP12 FXR1 FAM120A CEP78 PRRC2C ANKRD17 MACF1 TMEM131 PRRC2B INO80E | 1.31e-08 | 724 | 147 | 17 | 36232890 |
| Pubmed | FAT4 GOLGA6L2 RSF1 USP24 CHD7 CASZ1 PPP4R4 ANKRD36B SALL1 ASXL3 PAXIP1 ANKRD17 CDK5RAP2 RCOR3 FGD5 PRRC2B | 1.45e-08 | 638 | 147 | 16 | 31182584 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RANBP2 SLK TCOF1 UTP14A RSF1 TACC2 NSUN2 RTN1 ADD1 AKAP12 MRTFB PRRC2C ZNF638 KMT2A ANKRD17 MACF1 PPP6R2 TP53BP1 PRRC2B | 1.72e-08 | 934 | 147 | 19 | 33916271 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TCOF1 TACC2 CHD7 CEP192 RABGAP1 HUWE1 MRTFB SALL1 BRF1 CTR9 PRRC2C MACF1 PPP6R2 TP53BP1 PRRC2B | 3.36e-08 | 588 | 147 | 15 | 38580884 |
| Pubmed | FAT4 CDC42EP4 TCOF1 UTP14A RNF213 SRPRA CEP192 HUWE1 CLCC1 USP19 ADD1 AKAP12 DMXL1 ZNF638 CDK5RAP2 ZFHX3 PRRC2B | 3.64e-08 | 777 | 147 | 17 | 35844135 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SOX5 RANBP2 CHD7 KMT2C SALL1 ASXL3 PAXIP1 KMT2A ZFHX3 ZHX1 PRRC2B INO80E | 3.67e-08 | 351 | 147 | 12 | 38297188 |
| Pubmed | SOX5 SLK MRPS28 UTP14A PSMD1 CHD7 CEP192 NSUN2 KMT2C SALL1 FAM120A PRRC2C PAXIP1 ZNF638 KMT2A ANKRD17 RCOR3 ZFHX3 CEP152 ZHX1 TP53BP1 PRRC2B INO80E | 3.68e-08 | 1429 | 147 | 23 | 35140242 | |
| Pubmed | 3.80e-08 | 9 | 147 | 4 | 9733766 | ||
| Pubmed | TLK2 GINS3 ZCWPW1 CENPC KNSTRN UTP14A NSUN2 KHDC4 CLCC1 USP19 PPP4R4 TGIF1 ZBTB49 KMT2C FXR1 SALL1 BRF1 CTR9 PAXIP1 KMT2A ANKRD17 SSH2 | 4.51e-08 | 1327 | 147 | 22 | 32694731 | |
| Pubmed | 8.48e-08 | 86 | 147 | 7 | 37253089 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 TLK2 CDK17 RANBP2 HDAC6 CENPC KNSTRN TACC2 CEP192 NSUN2 SPECC1 AKAP12 FAM120A CEP78 RGPD3 CDK5RAP2 RCOR3 CEP152 TP53BP1 PRRC2B | 9.81e-08 | 1155 | 147 | 20 | 20360068 |
| Pubmed | RANBP2 RSF1 CHD7 HUWE1 ZNF831 KMT2C FXR1 FAM120A PRRC2C ZNF638 KMT2A RCOR3 TP53BP1 | 1.12e-07 | 469 | 147 | 13 | 27634302 | |
| Pubmed | TCOF1 UTP14A LAMA1 HUWE1 NSUN2 WTAP FAM120A CTR9 ANKRD17 PRRC2B | 1.28e-07 | 251 | 147 | 10 | 28077445 | |
| Pubmed | RANBP2 HDAC6 TCOF1 RSF1 USP24 PSMD1 TACC2 HUWE1 FAM120A CTR9 ZNF638 TMEM131 TP53BP1 | 2.49e-07 | 503 | 147 | 13 | 16964243 | |
| Pubmed | 2.58e-07 | 101 | 147 | 7 | 10997877 | ||
| Pubmed | 2.95e-07 | 4 | 147 | 3 | 19703992 | ||
| Pubmed | STIL binding to Polo-box 3 of PLK4 regulates centriole duplication. | 2.95e-07 | 4 | 147 | 3 | 26188084 | |
| Pubmed | 4.03e-07 | 15 | 147 | 4 | 14697343 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | CDK17 CASC3 TTC3 FXR1 FAM120A PRRC2C SRGAP1 OSBPL5 ZNF638 ANKRD17 TMEM131 PRRC2B | 6.97e-07 | 462 | 147 | 12 | 31138677 |
| Pubmed | SLK UTP14A SRPRA NSUN2 FAM120A CEP78 CTR9 PRRC2C CARD6 ZNF638 KMT2A ANKRD17 PPP6R2 PRRC2B | 7.51e-07 | 650 | 147 | 14 | 38777146 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK17 CASC3 CDC42EP4 MRPS28 CEP192 STIL SPECC1 PPP4R4 FXR1 PRRC2C SRGAP1 KMT2A ANKRD17 MACF1 CEP152 SSH2 | 8.26e-07 | 861 | 147 | 16 | 36931259 |
| Pubmed | 1.13e-06 | 246 | 147 | 9 | 15345747 | ||
| Pubmed | UTP14A RNF213 KHDC4 CASZ1 PPP4R4 PPP1R26 FAM120A MACF1 CEP152 ANKRD24 SSH2 PPP6R2 | 1.37e-06 | 493 | 147 | 12 | 15368895 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | CASC3 COL15A1 MRPS28 UTP14A RNF213 PSMD1 SRPRA TACC2 RABGAP1 HUWE1 TTC3 RTN1 CLCC1 USP19 FXR1 LMF2 FAM120A CDK5RAP2 TMEM131 DDX4 PRRC2B | 1.41e-06 | 1496 | 147 | 21 | 32877691 |
| Pubmed | 1.43e-06 | 130 | 147 | 7 | 12421765 | ||
| Pubmed | 2.56e-06 | 7 | 147 | 3 | 21205196 | ||
| Pubmed | 2.56e-06 | 7 | 147 | 3 | 18949001 | ||
| Pubmed | 2.56e-06 | 7 | 147 | 3 | 25187515 | ||
| Pubmed | 2.56e-06 | 7 | 147 | 3 | 9037092 | ||
| Pubmed | 2.56e-06 | 7 | 147 | 3 | 8603673 | ||
| Pubmed | 2.56e-06 | 7 | 147 | 3 | 26632511 | ||
| Pubmed | 2.56e-06 | 7 | 147 | 3 | 24403063 | ||
| Pubmed | 2.56e-06 | 7 | 147 | 3 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 2.56e-06 | 7 | 147 | 3 | 11353387 | |
| Pubmed | 2.56e-06 | 7 | 147 | 3 | 30944974 | ||
| Pubmed | 2.56e-06 | 7 | 147 | 3 | 38838144 | ||
| Pubmed | 2.56e-06 | 7 | 147 | 3 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 2.56e-06 | 7 | 147 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 2.56e-06 | 7 | 147 | 3 | 17372272 | |
| Pubmed | 2.56e-06 | 7 | 147 | 3 | 38657106 | ||
| Pubmed | 2.56e-06 | 7 | 147 | 3 | 12191015 | ||
| Pubmed | 2.56e-06 | 7 | 147 | 3 | 22821000 | ||
| Pubmed | 2.56e-06 | 7 | 147 | 3 | 20682751 | ||
| Pubmed | CASC3 RNF213 SRPRA CHD7 HUWE1 PRKRIP1 RTN1 CLCC1 ADD1 SPDL1 FXR1 FAM120A ZNF638 TMEM131 | 3.05e-06 | 733 | 147 | 14 | 34672954 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.13e-06 | 208 | 147 | 8 | 33230847 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | CDK17 MRPS28 CEP192 HUWE1 ADGRG4 AKAP12 FAM120A CEP78 PRRC2C CEP250 KMT2A ANKRD17 PPP6R2 | 3.54e-06 | 639 | 147 | 13 | 23443559 |
| Pubmed | RANBP2 GINS3 RNMT HDAC6 MRPS28 TCOF1 UTP14A PSMD1 HUWE1 NSUN2 WTAP PASK FXR1 FAM120A CEP78 PRRC2C TTLL11 ZNF638 PPP6R2 | 3.85e-06 | 1335 | 147 | 19 | 29229926 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 4.08e-06 | 8 | 147 | 3 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 4.08e-06 | 8 | 147 | 3 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 4.08e-06 | 8 | 147 | 3 | 28745977 | |
| Pubmed | 4.08e-06 | 8 | 147 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 4.08e-06 | 8 | 147 | 3 | 21310149 | |
| Pubmed | SLK TCOF1 USP24 HUWE1 ADD1 SPDL1 KMT2C MRTFB PRRC2C KMT2A TP53BP1 PRRC2B | 4.13e-06 | 549 | 147 | 12 | 38280479 | |
| Pubmed | Proteomic characterization of the human centrosome by protein correlation profiling. | 4.26e-06 | 26 | 147 | 4 | 14654843 | |
| Pubmed | CDK17 MRPS28 CENPC TCOF1 UTP14A SRPRA CEP192 TTC3 CLCC1 ADD1 AKAP12 DMXL1 PASK FAM120A CTR9 CDK5RAP2 MACF1 TMEM131 PPP6R2 TP53BP1 | 4.88e-06 | 1487 | 147 | 20 | 33957083 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RANBP2 SLK RNMT HDAC6 MRPS28 TCOF1 RNF213 RABGAP1 HUWE1 NSUN2 CLCC1 WTAP USP19 AKAP12 FXR1 MRTFB ANKRD17 TP53BP1 PRRC2B | 5.41e-06 | 1367 | 147 | 19 | 32687490 |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 6.10e-06 | 9 | 147 | 3 | 18394993 | |
| Pubmed | 6.10e-06 | 9 | 147 | 3 | 11553612 | ||
| Pubmed | 6.10e-06 | 9 | 147 | 3 | 10601307 | ||
| Pubmed | 6.10e-06 | 9 | 147 | 3 | 28100513 | ||
| Pubmed | 6.10e-06 | 9 | 147 | 3 | 28877029 | ||
| Pubmed | 6.10e-06 | 9 | 147 | 3 | 17887960 | ||
| Pubmed | RANBP2 CDC42EP4 PSMD1 KMT2C KIAA1549L CEP250 NAV3 ANKRD17 MACF1 ANKRD24 ZHX1 | 7.62e-06 | 486 | 147 | 11 | 20936779 | |
| Pubmed | HDAC6 CENPC RSF1 PSMD1 WTAP AKAP12 PPP1R26 KMT2C CDK5RAP2 RCOR3 FGD5 SSH2 PRRC2B | 7.94e-06 | 689 | 147 | 13 | 36543142 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 8.69e-06 | 10 | 147 | 3 | 8857542 | |
| Pubmed | 8.69e-06 | 10 | 147 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 8.69e-06 | 10 | 147 | 3 | 16332688 | |
| Pubmed | 8.69e-06 | 10 | 147 | 3 | 21859863 | ||
| Pubmed | RANBP2 CENPC RNF213 PSMD1 SRPRA CEP192 HUWE1 CLCC1 PPP4R4 CTR9 ZNF638 CDK5RAP2 SSH2 PPP6R2 SLC29A1 PRRC2B | 1.02e-05 | 1049 | 147 | 16 | 27880917 | |
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.19e-05 | 11 | 147 | 3 | 35771867 | |
| Pubmed | 1.19e-05 | 11 | 147 | 3 | 17069463 | ||
| Pubmed | 1.19e-05 | 11 | 147 | 3 | 34110283 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 HDAC6 MRPS28 CENPC UTP14A RSF1 PSMD1 CHD7 HUWE1 NSUN2 FXR1 FAM120A CTR9 ZNF638 ANKRD17 MACF1 DDX43 TP53BP1 | 1.75e-05 | 1353 | 147 | 18 | 29467282 |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 36122629 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 37759260 | ||
| Pubmed | TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemia. | 1.77e-05 | 2 | 147 | 2 | 25349154 | |
| Pubmed | Expression of MEGF10 in cholinergic and glutamatergic neurons. | 1.77e-05 | 2 | 147 | 2 | 28526325 | |
| Pubmed | CHD7 and 53BP1 regulate distinct pathways for the re-ligation of DNA double-strand breaks. | 1.77e-05 | 2 | 147 | 2 | 33188175 | |
| Pubmed | DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis. | 1.77e-05 | 2 | 147 | 2 | 28475402 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 28970258 | ||
| Pubmed | 1.82e-05 | 347 | 147 | 9 | 17114649 | ||
| Pubmed | 1.83e-05 | 76 | 147 | 5 | 27542412 | ||
| Pubmed | TLK2 RANBP2 KNSTRN CHD7 PRKRIP1 NSUN2 KHDC4 TGIF1 KMT2C FAM120A CTR9 PRRC2C PAXIP1 KMT2A TP53BP1 PRRC2B | 1.88e-05 | 1103 | 147 | 16 | 34189442 | |
| Pubmed | 1.98e-05 | 268 | 147 | 8 | 33640491 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 2.05e-05 | 13 | 147 | 3 | 31427429 | |
| Pubmed | CASC3 MRPS28 TCOF1 KNSTRN SRPRA CHD7 PRKRIP1 NSUN2 ADD1 ANKRD36B FXR1 FAM120A CEP78 PRRC2C KMT2A ANKRD17 PRRC2B INO80E | 2.08e-05 | 1371 | 147 | 18 | 36244648 | |
| Pubmed | 2.29e-05 | 449 | 147 | 10 | 31732153 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.66e-05 | 203 | 147 | 7 | 22083510 | |
| Pubmed | 2.66e-05 | 203 | 147 | 7 | 35012549 | ||
| Pubmed | RGPD4 RANBP2 USP24 PSMD1 GRIA2 SRPRA TACC2 RABGAP1 HUWE1 RTN1 PRRC2C RGPD3 NAV3 MACF1 PPP6R2 TP53BP1 | 2.77e-05 | 1139 | 147 | 16 | 36417873 | |
| Pubmed | 2.78e-05 | 281 | 147 | 8 | 24163370 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 3.00e-05 | 370 | 147 | 9 | 22922362 | |
| Interaction | MAPRE1 interactions | LCA5 CASC3 RANBP2 HDAC6 KNSTRN UTP14A TACC2 NSUN2 SPECC1 ADD1 SPDL1 FXR1 PRRC2C CEP250 NAV3 CDK5RAP2 MACF1 TMEM131 PRRC2B | 5.46e-09 | 514 | 145 | 19 | int:MAPRE1 |
| Interaction | DYNLL2 interactions | TLK2 LCA5 HDAC6 KNSTRN TTC3 PKIG KMT2C PAXIP1 CDK5RAP2 RCOR3 CEP152 TP53BP1 | 4.61e-07 | 263 | 145 | 12 | int:DYNLL2 |
| Interaction | DYNLL1 interactions | TLK2 LCA5 HDAC6 MRPS28 KNSTRN WTAP TGOLN2 SPDL1 PKIG KMT2C FXR1 CDK5RAP2 RCOR3 CEP152 ZHX1 TP53BP1 | 8.60e-07 | 510 | 145 | 16 | int:DYNLL1 |
| Interaction | SIRT7 interactions | RANBP2 TCOF1 UTP14A RSF1 USP24 PSMD1 CHD7 HUWE1 NSUN2 FXR1 FAM120A PREP PRRC2C ZNF638 KMT2A ANKRD17 MACF1 TP53BP1 PRRC2B | 1.69e-06 | 744 | 145 | 19 | int:SIRT7 |
| Interaction | YWHAZ interactions | TLK2 CDK17 LCA5 SLK HDAC6 MRPS28 RASGRF1 RSF1 SRPRA TACC2 CEP192 HUWE1 SAMSN1 SPECC1 WTAP PPP4R4 ASXL3 SRGAP1 ZNF638 KMT2A ANKRD17 CDK5RAP2 MACF1 SSH2 TP53BP1 INVS | 2.39e-06 | 1319 | 145 | 26 | int:YWHAZ |
| Interaction | GAPDH interactions | CDK17 CASC3 RANBP2 HDAC6 FRMPD1 GRIA2 HUWE1 QRICH2 AKAP12 TGOLN2 SPDL1 PRRC2C ASXL3 MACF1 ZFHX3 ABCC12 FGD5 | 9.20e-06 | 686 | 145 | 17 | int:GAPDH |
| Interaction | RNF214 interactions | 1.02e-05 | 104 | 145 | 7 | int:RNF214 | |
| Interaction | RCOR1 interactions | SOX5 RANBP2 USP24 PSMD1 CHD7 RABGAP1 HUWE1 SPDL1 MRTFB SALL1 ANKRD17 RCOR3 ZFHX3 TP53BP1 | 1.37e-05 | 494 | 145 | 14 | int:RCOR1 |
| Interaction | PAX6 interactions | TLK2 SOX5 SLC12A8 CHD7 TTC3 KMT2C SALL1 PAXIP1 RCOR3 ZFHX3 ZHX1 PRRC2B | 1.39e-05 | 366 | 145 | 12 | int:PAX6 |
| Interaction | KCNA3 interactions | RANBP2 HDAC6 TCOF1 LAMA1 USP24 AKNAD1 RNF213 PSMD1 SRPRA SPECC1 CLCC1 ADD1 AKAP12 KMT2C PRRC2C KMT2A ANKRD17 CDK5RAP2 MACF1 | 1.61e-05 | 871 | 145 | 19 | int:KCNA3 |
| Interaction | FEV interactions | 1.66e-05 | 203 | 145 | 9 | int:FEV | |
| Interaction | SMG7 interactions | PSMD1 RABGAP1 STIL FXR1 SALL1 FAM120A PAXIP1 ANKRD17 RCOR3 CEP152 PRRC2B | 2.03e-05 | 319 | 145 | 11 | int:SMG7 |
| Interaction | SOX7 interactions | 2.79e-05 | 82 | 145 | 6 | int:SOX7 | |
| Interaction | BORCS6 interactions | 3.25e-05 | 170 | 145 | 8 | int:BORCS6 | |
| Interaction | FMR1 interactions | CASC3 RANBP2 TCOF1 TACC2 CHD7 WTAP FXR1 FAM120A PRRC2C ANKRD17 CDK5RAP2 MACF1 TP53BP1 PRRC2B | 3.36e-05 | 536 | 145 | 14 | int:FMR1 |
| Interaction | EGR2 interactions | 3.39e-05 | 171 | 145 | 8 | int:EGR2 | |
| Interaction | GSC interactions | 3.91e-05 | 87 | 145 | 6 | int:GSC | |
| Interaction | YWHAH interactions | CDK17 LCA5 CASC3 CDC42EP4 MRPS28 CEP192 HUWE1 STIL SAMSN1 SPECC1 PPP4R4 FXR1 PRRC2C SRGAP1 OSBPL5 ZNF638 KMT2A ANKRD17 MACF1 CEP152 SSH2 | 4.15e-05 | 1102 | 145 | 21 | int:YWHAH |
| Interaction | CNOT9 interactions | PSMD1 CEP192 PASK SALL1 PRRC2C ANKRD17 TMEM131 CEP152 PRRC2B | 4.59e-05 | 231 | 145 | 9 | int:CNOT9 |
| Interaction | GSK3B interactions | HDAC6 PSMD1 GRIA2 CEP192 PRKRIP1 TICAM2 NSUN2 RTN1 ADD1 PASK CABYR FXR1 FAM120A PRRC2C HECW2 MACF1 CEP152 ZHX1 | 5.30e-05 | 868 | 145 | 18 | int:GSK3B |
| Interaction | PYHIN1 interactions | TCOF1 UTP14A LAMA1 RSF1 HUWE1 NSUN2 WTAP FAM120A CTR9 ANKRD17 PRRC2B | 5.79e-05 | 358 | 145 | 11 | int:PYHIN1 |
| Interaction | LHX3 interactions | 5.92e-05 | 185 | 145 | 8 | int:LHX3 | |
| Interaction | PCNT interactions | KNSTRN CEP192 HUWE1 STIL CDK5RAP2 MACF1 CEP152 ANKRD24 TP53BP1 | 6.37e-05 | 241 | 145 | 9 | int:PCNT |
| Interaction | SEC62 interactions | GRIA2 SRPRA RABGAP1 HUWE1 RTN1 CLCC1 TGOLN2 SPDL1 MRTFB LMF2 SCN4A OSBPL5 TMEM131 | 7.66e-05 | 506 | 145 | 13 | int:SEC62 |
| Interaction | NAA40 interactions | RANBP2 SLK TCOF1 UTP14A RSF1 TACC2 NSUN2 RTN1 ADD1 AKAP12 MRTFB PRRC2C ZNF638 KMT2A ANKRD17 MACF1 PPP6R2 TP53BP1 PRRC2B | 7.74e-05 | 978 | 145 | 19 | int:NAA40 |
| Interaction | YWHAG interactions | CDK17 LCA5 CASC3 SLK USP24 PSMD1 CEP192 HUWE1 SAMSN1 SPECC1 PPP4R4 TGOLN2 FXR1 CEP78 PRRC2C SRGAP1 CEP250 ZNF638 KMT2A ANKRD17 MACF1 SSH2 | 8.50e-05 | 1248 | 145 | 22 | int:YWHAG |
| Interaction | HSPH1 interactions | SLK HDAC6 PSMD1 RABGAP1 HUWE1 STIL ADD1 TGOLN2 BRF1 PREP HECW2 ZNF638 | 9.87e-05 | 448 | 145 | 12 | int:HSPH1 |
| Interaction | SLC35G1 interactions | 1.01e-04 | 34 | 145 | 4 | int:SLC35G1 | |
| Interaction | NINL interactions | LCA5 UTP14A CEP192 HUWE1 STIL PASK CEP250 RCOR3 ZFHX3 TMEM131 CEP152 PRRC2B | 1.21e-04 | 458 | 145 | 12 | int:NINL |
| Interaction | CALD1 interactions | 1.31e-04 | 265 | 145 | 9 | int:CALD1 | |
| Interaction | HDAC1 interactions | RANBP2 USP24 PSMD1 SRPRA RABGAP1 SAMSN1 CASZ1 USP19 SPDL1 TGIF1 MRTFB SALL1 CEP250 ZNF638 KMT2A ANKRD17 CDK5RAP2 RCOR3 ZFHX3 ZHX1 | 1.35e-04 | 1108 | 145 | 20 | int:HDAC1 |
| Interaction | PRDX2 interactions | 1.38e-04 | 329 | 145 | 10 | int:PRDX2 | |
| Interaction | NFIC interactions | 1.43e-04 | 210 | 145 | 8 | int:NFIC | |
| Interaction | TDRD3 interactions | 1.53e-04 | 212 | 145 | 8 | int:TDRD3 | |
| Interaction | TBR1 interactions | 1.68e-04 | 113 | 145 | 6 | int:TBR1 | |
| Interaction | CDKL5 interactions | 1.68e-04 | 113 | 145 | 6 | int:CDKL5 | |
| Interaction | SOX5 interactions | 1.74e-04 | 162 | 145 | 7 | int:SOX5 | |
| Interaction | NANOG interactions | RANBP2 PSMD1 CHD7 HUWE1 NSUN2 SPECC1 WTAP KMT2C FXR1 SALL1 PAXIP1 TP53BP1 | 1.91e-04 | 481 | 145 | 12 | int:NANOG |
| Interaction | PHF21A interactions | RANBP2 USP24 PSMD1 CHD7 RABGAP1 HUWE1 MRTFB SALL1 RCOR3 ZFHX3 | 1.94e-04 | 343 | 145 | 10 | int:PHF21A |
| Interaction | NR3C1 interactions | FAT4 ZBTB20 HDAC6 GOLGA6L2 RSF1 USP24 CHD7 CASZ1 PPP4R4 ANKRD36B SALL1 ASXL3 PAXIP1 ANKRD17 CDK5RAP2 RCOR3 FGD5 PRRC2B | 2.24e-04 | 974 | 145 | 18 | int:NR3C1 |
| Interaction | POLR1E interactions | RANBP2 CENPC TCOF1 UTP14A PSMD1 CHD7 CASZ1 CTR9 PAXIP1 KMT2A | 2.28e-04 | 350 | 145 | 10 | int:POLR1E |
| Interaction | NRIP1 interactions | 2.34e-04 | 170 | 145 | 7 | int:NRIP1 | |
| Interaction | CACYBP interactions | 2.44e-04 | 288 | 145 | 9 | int:CACYBP | |
| Interaction | NXF1 interactions | CASC3 RANBP2 FAT4 HDAC6 KNSTRN UTP14A TATDN2 PSMD1 CEP192 NSUN2 SPECC1 KHDC4 PPP1R26 HINFP ANKRD44 FAM120A CEP78 CTR9 CEP250 MACF1 TP53BP1 PRRC2B | 2.48e-04 | 1345 | 145 | 22 | int:NXF1 |
| Interaction | KLF16 interactions | SOX5 UTP14A PSMD1 CHD7 HUWE1 NSUN2 TGOLN2 CTR9 PRRC2C ZHX1 PRRC2B | 2.60e-04 | 425 | 145 | 11 | int:KLF16 |
| Interaction | ANPEP interactions | 2.69e-04 | 174 | 145 | 7 | int:ANPEP | |
| Interaction | SRP9 interactions | TLK2 CASC3 SRPRA HUWE1 NSUN2 CTR9 PRRC2C PAXIP1 ANKRD17 CEP152 PRRC2B | 2.71e-04 | 427 | 145 | 11 | int:SRP9 |
| Interaction | PAX7 interactions | 2.78e-04 | 124 | 145 | 6 | int:PAX7 | |
| Interaction | TLX1 interactions | 2.79e-04 | 175 | 145 | 7 | int:TLX1 | |
| Interaction | C2CD4B interactions | 2.79e-04 | 44 | 145 | 4 | int:C2CD4B | |
| Interaction | ATOH1 interactions | 2.80e-04 | 80 | 145 | 5 | int:ATOH1 | |
| Interaction | ELL interactions | 2.80e-04 | 80 | 145 | 5 | int:ELL | |
| Interaction | BUB3 interactions | 2.82e-04 | 232 | 145 | 8 | int:BUB3 | |
| Interaction | CNOT2 interactions | 3.09e-04 | 178 | 145 | 7 | int:CNOT2 | |
| Interaction | PCM1 interactions | LCA5 KNSTRN CEP192 STIL TTC3 SPDL1 FXR1 SRGAP1 CEP250 CDK5RAP2 CEP152 | 3.11e-04 | 434 | 145 | 11 | int:PCM1 |
| Interaction | POU5F1 interactions | SOX5 TCOF1 LAMA1 CHD7 HUWE1 SPECC1 SALL1 PAXIP1 ANKRD17 ZFHX3 DDX4 TP53BP1 PRRC2B | 3.13e-04 | 584 | 145 | 13 | int:POU5F1 |
| Interaction | EIF4ENIF1 interactions | 3.30e-04 | 300 | 145 | 9 | int:EIF4ENIF1 | |
| Interaction | SUMO2 interactions | RANBP2 CENPC RNF213 HUWE1 NSUN2 SALL1 BRF1 CEP78 CTR9 ZNF638 RCOR3 ZHX1 TP53BP1 | 3.51e-04 | 591 | 145 | 13 | int:SUMO2 |
| Interaction | RGPD3 interactions | 3.61e-04 | 47 | 145 | 4 | int:RGPD3 | |
| Interaction | IRF4 interactions | 3.72e-04 | 85 | 145 | 5 | int:IRF4 | |
| Interaction | SYNE3 interactions | RANBP2 SRPRA CEP192 STIL RTN1 CLCC1 CDK5RAP2 MACF1 TMEM131 CEP152 PRRC2B | 3.77e-04 | 444 | 145 | 11 | int:SYNE3 |
| Interaction | FXR1 interactions | SOX5 RANBP2 TCOF1 GRIA2 TACC2 TTC3 SPECC1 FXR1 FAM120A KIAA1549L PRRC2C ANKRD17 TP53BP1 PRRC2B | 3.98e-04 | 679 | 145 | 14 | int:FXR1 |
| Interaction | YTHDF3 interactions | 4.17e-04 | 246 | 145 | 8 | int:YTHDF3 | |
| Interaction | YWHAQ interactions | CDK17 LCA5 SLK HDAC6 PSMD1 CEP192 SAMSN1 SPECC1 WTAP PPP4R4 SRGAP1 CEP250 ZNF638 KMT2A ANKRD17 MACF1 RCOR3 FGD5 SSH2 | 4.26e-04 | 1118 | 145 | 19 | int:YWHAQ |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.73e-04 | 115 | 90 | 5 | 769 | |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 3.63e-04 | 6 | 90 | 2 | 699 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TLK2 CDK17 RANBP2 SLK ZBTB20 MAN2A1 CENPC USP24 RABGAP1 STIL TGIF1 FXR1 ELL2 PRRC2C NAV3 ZNF638 ANKRD17 MACF1 ZFHX3 TMEM131 TP53BP1 | 1.27e-08 | 856 | 146 | 21 | M4500 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 8.01e-07 | 180 | 146 | 9 | M8239 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | CASC3 RANBP2 SLK RNMT RASGRF1 CENPC PSMD1 SRPRA CHD7 HUWE1 TTC3 ERICH5 TGOLN2 KMT2C FXR1 RCOR3 SLC29A1 IL17RB PRRC2B | 1.39e-06 | 946 | 146 | 19 | M39169 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TLK2 CDK17 SLK MAN2A1 USP24 RABGAP1 STIL FXR1 PRRC2C ZNF638 ANKRD17 TMEM131 | 1.24e-05 | 466 | 146 | 12 | M13522 |
| Coexpression | GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 1.54e-05 | 197 | 146 | 8 | M8980 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 1.65e-05 | 199 | 146 | 8 | M7319 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CDK17 RANBP2 SLK CENPC RSF1 USP24 RNF213 SRPRA HUWE1 SAMSN1 ZNF831 ADD1 TGOLN2 SIRPG ANKRD44 KMT2C ZNF276 ZNF638 KMT2A MACF1 SSH2 PRRC2B | 2.75e-05 | 1492 | 146 | 22 | M40023 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | HSPBAP1 USP24 CHD7 ZNF831 TTC3 ANKRD44 KMT2C PRRC2C CARD6 KMT2A MACF1 SSH2 | 3.24e-06 | 336 | 144 | 12 | GSM538413_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CDK17 RANBP2 CENPC UTP14A RSF1 CHD7 CEP192 STIL TTC3 SPDL1 FXR1 PRRC2C PAXIP1 ZNF638 | 1.62e-05 | 532 | 144 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | TLK2 GINS3 SLK USP24 PSMD1 CHD7 WTAP FAM120A ANKRD17 CDK5RAP2 MACF1 ZFHX3 TMEM131 ZHX1 | 3.08e-05 | 564 | 144 | 14 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | CDK17 RANBP2 ZBTB20 USP24 RNF213 HUWE1 ANKRD44 KMT2C KMT2A MACF1 TMEM131 TP53BP1 | 1.63e-12 | 188 | 147 | 12 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | CDK17 RANBP2 MAN2A1 CENPC RNF213 ANKRD36B ANKRD44 KMT2C KMT2A MACF1 | 9.06e-10 | 192 | 147 | 10 | 47646d7e4990be85072987f92bf18d52f8da752e |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | RNMT USP24 RNF213 AKAP12 ANKRD44 KMT2C CEP78 PRRC2C KMT2A MACF1 | 1.16e-09 | 197 | 147 | 10 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | CDK17 RANBP2 ZBTB20 MAN2A1 RNF213 HUWE1 ANKRD36B ANKRD44 MACF1 | 9.66e-09 | 181 | 147 | 9 | f2315414e714ac86211546a935660c4be6e85f1b |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.20e-08 | 199 | 147 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.29e-08 | 200 | 147 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-07 | 179 | 147 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-07 | 195 | 147 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-07 | 195 | 147 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 8.92e-07 | 156 | 147 | 7 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.15e-06 | 162 | 147 | 7 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.92e-06 | 175 | 147 | 7 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-06 | 182 | 147 | 7 | f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.32e-06 | 190 | 147 | 7 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.43e-06 | 191 | 147 | 7 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 3.55e-06 | 192 | 147 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.35e-06 | 198 | 147 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | lymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass | 4.50e-06 | 199 | 147 | 7 | 945fbf5845403a8b22d04963f50ad69c414b6153 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 4.50e-06 | 199 | 147 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.65e-06 | 200 | 147 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 4.65e-06 | 200 | 147 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.38e-05 | 157 | 147 | 6 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.47e-05 | 174 | 147 | 6 | 6c36d607c48267a75ab4da6fb2fe3f931d1b3b52 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 175 | 147 | 6 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 176 | 147 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 176 | 147 | 6 | 1df7b6ce2519ad99bacbbaf1a8d5929e11513faa | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 2.64e-05 | 176 | 147 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 2.72e-05 | 177 | 147 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 179 | 147 | 6 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 179 | 147 | 6 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.90e-05 | 179 | 147 | 6 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 180 | 147 | 6 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 180 | 147 | 6 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 184 | 147 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.48e-05 | 185 | 147 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 185 | 147 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.48e-05 | 185 | 147 | 6 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.59e-05 | 186 | 147 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.70e-05 | 187 | 147 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 187 | 147 | 6 | d72012e94857606f39975cf672f6b8c2e0fe093e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-05 | 189 | 147 | 6 | 5c92516c3745ccbd480b15bb2b9077ab1d9ee5a0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.04e-05 | 190 | 147 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | (2)_5-FU-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 4.04e-05 | 190 | 147 | 6 | 6b391b8a3ffcbdec3acaf242bc52fc3fc9da77c8 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.04e-05 | 190 | 147 | 6 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.04e-05 | 190 | 147 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.16e-05 | 191 | 147 | 6 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 4.16e-05 | 191 | 147 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.16e-05 | 191 | 147 | 6 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.29e-05 | 192 | 147 | 6 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.29e-05 | 192 | 147 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 192 | 147 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 192 | 147 | 6 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 4.33e-05 | 59 | 147 | 4 | 74590437b1d9a2a8fe56d79b2e66803528b81298 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 193 | 147 | 6 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 193 | 147 | 6 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 193 | 147 | 6 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.41e-05 | 193 | 147 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 193 | 147 | 6 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 193 | 147 | 6 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.41e-05 | 193 | 147 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 193 | 147 | 6 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 193 | 147 | 6 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 194 | 147 | 6 | e55dc30e200c9f576804acb642175eb4fa9146b5 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 195 | 147 | 6 | 3969b8d5fcec8ef1831531a781f7bbcebab5a4ba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.81e-05 | 196 | 147 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-05 | 197 | 147 | 6 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-05 | 197 | 147 | 6 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 4.95e-05 | 197 | 147 | 6 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 4.95e-05 | 197 | 147 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.95e-05 | 197 | 147 | 6 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.95e-05 | 197 | 147 | 6 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.09e-05 | 198 | 147 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.09e-05 | 198 | 147 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.09e-05 | 198 | 147 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.09e-05 | 198 | 147 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 5.09e-05 | 198 | 147 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-05 | 198 | 147 | 6 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.23e-05 | 199 | 147 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-05 | 199 | 147 | 6 | a76aa30fb264bdcbc0cb09113f814fc5a89e7319 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.23e-05 | 199 | 147 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 5.38e-05 | 200 | 147 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-05 | 200 | 147 | 6 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.38e-05 | 200 | 147 | 6 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-05 | 200 | 147 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-05 | 200 | 147 | 6 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-05 | 200 | 147 | 6 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-05 | 200 | 147 | 6 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-05 | 200 | 147 | 6 | a3b09580738783c6bff31ea33d5188912e56b8a7 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-professional_antigen_presenting_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 139 | 147 | 5 | 292533e04178dd36d57377562077f9deb2cb9746 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.28e-04 | 147 | 147 | 5 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.45e-04 | 151 | 147 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 1.59e-04 | 154 | 147 | 5 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 1.69e-04 | 156 | 147 | 5 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-04 | 157 | 147 | 5 | e9d0300361b06aec3c216f8af15f09e14b12a4da | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.79e-04 | 158 | 147 | 5 | e9657d8960d499832f9f9b45b5a6f4388551b7e1 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.96e-04 | 161 | 147 | 5 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.07e-04 | 163 | 147 | 5 | 977a970b1296234c22178420294cea73506ee02f | |
| ToppCell | mild-Myeloid-Eosinophils|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.07e-04 | 163 | 147 | 5 | 7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 165 | 147 | 5 | 475905d608fac628960188ae4a18010b8097417e | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 165 | 147 | 5 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.46e-05 | 49 | 87 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.92e-05 | 50 | 87 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Disease | Cone-rod dystrophy and hearing loss | 2.30e-05 | 2 | 142 | 2 | cv:CN263092 | |
| Disease | Autosomal recessive primary microcephaly | 4.76e-05 | 15 | 142 | 3 | cv:C3711387 | |
| Disease | neutrophil gelatinase-associated lipocalin measurement | 6.88e-05 | 3 | 142 | 2 | EFO_0021964 | |
| Disease | Autosomal Recessive Primary Microcephaly | 1.57e-04 | 22 | 142 | 3 | C3711387 | |
| Disease | Primary microcephaly | 1.57e-04 | 22 | 142 | 3 | C0431350 | |
| Disease | response to antipsychotic drug | 2.03e-04 | 60 | 142 | 4 | GO_0097332 | |
| Disease | cortical thickness | SOX5 MRPS28 LAMA1 SLC12A8 TACC2 CHD7 RABGAP1 SPECC1 PCDHB16 NAV3 KMT2A CDK5RAP2 MACF1 TMEM131 SSH2 | 3.18e-04 | 1113 | 142 | 15 | EFO_0004840 |
| Disease | hoarding disorder | 6.93e-04 | 36 | 142 | 3 | EFO_0803361 | |
| Disease | eye color | 9.53e-04 | 90 | 142 | 4 | EFO_0003949 | |
| Disease | Congenital small ears | 1.02e-03 | 41 | 142 | 3 | C0152423 | |
| Disease | metabolite measurement, body weight gain | 1.47e-03 | 12 | 142 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | Mitral valve prolapse, response to surgery | 1.47e-03 | 12 | 142 | 2 | EFO_0009951, HP_0001634 | |
| Disease | Intellectual Disability | 1.50e-03 | 447 | 142 | 8 | C3714756 | |
| Disease | T wave morphology measurement | 2.01e-03 | 14 | 142 | 2 | EFO_0008398 | |
| Disease | unipolar depression | SOX5 KIRREL3-AS3 RNMT AKNAD1 RNF213 CHD7 RTN1 CLCC1 ANKRD44 FAM120A ASXL3 ZNF638 ZFHX3 LTBP2 | 2.09e-03 | 1206 | 142 | 14 | EFO_0003761 |
| Disease | Beta blocking agent use measurement | 2.28e-03 | 114 | 142 | 4 | EFO_0009929 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 2.32e-03 | 15 | 142 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | hepatoblastoma (is_marker_for) | 2.32e-03 | 15 | 142 | 2 | DOID:687 (is_marker_for) | |
| Disease | colorectal mucinous adenocarcinoma | 2.64e-03 | 16 | 142 | 2 | EFO_0009361 | |
| Disease | fibroblast growth factor basic measurement | 2.91e-03 | 59 | 142 | 3 | EFO_0008130 | |
| Disease | Prostatic Neoplasms | 3.05e-03 | 616 | 142 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.05e-03 | 616 | 142 | 9 | C0376358 | |
| Disease | body weight | SOX5 CDK17 RASGRF1 CHD7 CEP192 RABGAP1 HUWE1 EYS ASXL3 ZNF638 ZFHX3 LTBP2 DMP1 GPR151 | 3.13e-03 | 1261 | 142 | 14 | EFO_0004338 |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 3.35e-03 | 18 | 142 | 2 | OBA_2045175 | |
| Disease | cerebral microbleeds | 3.73e-03 | 19 | 142 | 2 | EFO_0010059 | |
| Disease | gestational age | 4.52e-03 | 138 | 142 | 4 | EFO_0005112 | |
| Disease | congenital heart disease (implicated_via_orthology) | 4.53e-03 | 69 | 142 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | coronary atherosclerosis measurement, traffic air pollution measurement | 4.55e-03 | 21 | 142 | 2 | EFO_0007908, EFO_0007938 | |
| Disease | periodontitis | 4.57e-03 | 223 | 142 | 5 | EFO_0000649 | |
| Disease | reaction time measurement | SOX5 TACC2 CEP192 ANKRD44 FXR1 KIAA1549L ZNF648 ZNF638 ZFHX3 | 4.68e-03 | 658 | 142 | 9 | EFO_0008393 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVADKDTSNESSSGS | 286 | P08173 | |
| LSKDSASQGTGQGDP | 1121 | O94986 | |
| NSSPNSSGGVKEDCT | 501 | O00472 | |
| NQTNGSSTTGDKPVE | 21 | Q5JRM2 | |
| AEGGESSDTQGPKVT | 231 | Q9NQI0 | |
| KASPEGKGTTANDAT | 706 | Q8IZF6 | |
| SKEDSGPSTRQASGE | 156 | Q86V15 | |
| DSQEEQKGESSASSP | 556 | Q02952 | |
| VSATDPDLGTNGTVK | 711 | Q6V0I7 | |
| EDTLNKPGSTAASGV | 56 | Q5M775 | |
| TEQTEAVGGLSSKPA | 131 | O75952 | |
| DGEKSGTVSPQKQSA | 656 | Q8N2N9 | |
| SPDATSGTGSQRKEE | 656 | Q5JTW2 | |
| KPTGAQATDTETTGV | 621 | Q8TF21 | |
| ASPNKVASSSEQEAG | 2066 | O75179 | |
| SSQGEPEDSTSKGEE | 2831 | Q9P2D1 | |
| VTSPDGSSEKQSQGE | 206 | Q9Y485 | |
| DEQSDSPSGSESKNG | 191 | Q9C0F0 | |
| SPSGSESKNGEADSS | 196 | Q9C0F0 | |
| QEAPSSTSQELGTKG | 1756 | Q96SN8 | |
| SASNVPSGKSTDEEE | 366 | Q9P2K3 | |
| PAKLNQSGTSVGTDE | 2281 | P49792 | |
| GTLSGDSTKQPSIEQ | 91 | Q9H0J4 | |
| GGSPTETAESQQLGK | 46 | Q8N7Y1 | |
| SAASTGQPDNDVTEG | 721 | Q08J23 | |
| QEVDQPTSGADTGTS | 571 | Q9P2P5 | |
| VRDSSSSPKQEDSGG | 1116 | Q96KG7 | |
| QDSQNEGSTDEKSSP | 206 | Q6ZW49 | |
| EGSTDEKSSPASSQE | 211 | Q6ZW49 | |
| PSTNNGSDDEKTGLK | 36 | Q9Y3P9 | |
| KSQPSSEEATTGEAA | 316 | Q96RG2 | |
| SEQTAKGPIAAGTSD | 1991 | Q8NEZ4 | |
| DEGSSSQKEESPSTL | 106 | P43363 | |
| PKGSSSQNGETDVSE | 321 | Q5T1H1 | |
| ESVEDGPKSSQSNFS | 81 | Q16706 | |
| SEKAINGPTSASGDD | 576 | P51114 | |
| NGPTSASGDDISKLQ | 581 | P51114 | |
| GTCGKSEGSPSENSQ | 406 | Q9NRM6 | |
| ELPSGNDTSGLENKT | 401 | P42262 | |
| TTADIGANTPDATKG | 181 | Q96PD5 | |
| NEKDSSKGPQSSSGV | 291 | Q8IVL0 | |
| EGSVGNKALVSPESS | 81 | Q6ZNL6 | |
| SQESQGSAASPSEPK | 191 | Q9ULH7 | |
| SSDPNSVASSKGDID | 621 | Q86VQ0 | |
| KINNGTNPETTTSEG | 51 | Q8N9W4 | |
| SGGPLSLSEENNDSK | 951 | P00451 | |
| SENGSVISNESGKPS | 1291 | Q6ZVL6 | |
| NSGFEESDSGATKSP | 556 | Q8N8A2 | |
| QASGTSSDEVQSPTG | 111 | Q00537 | |
| DPGDQTKAEGSSTAS | 496 | Q9NZB2 | |
| SKPEGGDSTQESESE | 176 | Q13316 | |
| TVSESQETPAGNSEG | 331 | Q8TDV0 | |
| DTQSIASDGTPQGEK | 3821 | Q7Z6Z7 | |
| EKPEGAETTAATTNG | 216 | Q9NZU5 | |
| ESDGKAQVTGPSQIS | 3121 | Q9UPN3 | |
| QPKEQGSSSSAEASG | 156 | Q9H875 | |
| SDNSETEGTPKLSDT | 76 | Q8NBZ0 | |
| PQQDGKSDGTETSTN | 191 | P48147 | |
| SDPDSGNNGKTISSI | 371 | Q9NRJ7 | |
| GPKEDSTSIKGNSDQ | 436 | Q8N573 | |
| PAKLNQSGTSVGTDE | 1306 | A6NKT7 | |
| GSQNLTTGTDKPEAA | 371 | Q96EW2 | |
| QSTQFSGGPTEDTEK | 431 | Q9BX69 | |
| PDTKSTVTGERQSGD | 136 | O15234 | |
| PGSAAQKETTEQSGK | 116 | O00341 | |
| TSEGQERKPSGSSQN | 231 | Q03188 | |
| KDSGDSPGDVSNNVS | 1131 | Q5SYB0 | |
| SKATASSPTQQDGRG | 2326 | Q9BV73 | |
| DGESLDEQPSSSSSK | 61 | Q9H3Q1 | |
| PSGSEQSDNESVQSG | 1096 | Q6PD62 | |
| RDGENSNKPGSATTT | 176 | Q5T1N1 | |
| IPDKGDSQAGQVTTS | 786 | Q14767 | |
| DVPKDKSSTGDGTQN | 111 | O43148 | |
| EKRSSGPSSSLDNGN | 476 | P10911 | |
| VGNDEKATSISTPSD | 891 | Q8TEP8 | |
| QNEIEGAGSKPASSS | 496 | Q7Z7F0 | |
| TGTPGAEAEQQDTAS | 3581 | Q03164 | |
| KVTSASFGEESTPGQ | 881 | Q9UBN7 | |
| SPGNGNKSSNSSEER | 306 | Q15007 | |
| DQSGSTEKTQPGEGL | 96 | Q6P6B1 | |
| KGSEGTALSASQDNP | 446 | Q9BQA5 | |
| DTEGSGSTQLLNEPK | 741 | P39059 | |
| AQTSGIEEPSETKGS | 686 | Q96T23 | |
| NKQTSKSEGTQPEGT | 536 | A0AV02 | |
| EVEAPVANKSGSGTS | 126 | Q9NSC2 | |
| DTAFQPSVGKDGSTD | 146 | Q9NXZ2 | |
| EGSRSQGPEKASQAS | 781 | O75170 | |
| TQSSGSGQGSEAPEK | 1386 | Q9HC10 | |
| SNTVSEDGPQAVSSG | 426 | A6NNC1 | |
| ERNKSGTIPSDSQGA | 276 | Q9Y283 | |
| RKTESGSDQSETPGA | 321 | Q9H0X9 | |
| KEAGGTTTSNNPEEA | 161 | Q9Y4I5 | |
| TESGSESGSSNAKEP | 31 | Q9Y2Q9 | |
| EDSSSNQSPAATKGP | 556 | Q16799 | |
| PAKLNQSGTSVGTDE | 1306 | Q7Z3J3 | |
| ENPKENDNDSGTGST | 741 | Q9H2G2 | |
| SQKADSEASSGPVTE | 811 | Q7Z6B7 | |
| PSTGSSSNDAAQVGK | 396 | Q93075 | |
| GNSVDPKSSGSKDTQ | 846 | Q6NUP7 | |
| DTSQGEKGAPRQSSS | 511 | P35499 | |
| QEGTVPDNTSSARGK | 271 | O75509 | |
| SAGAETDNAVPQGSK | 51 | Q9BRX5 | |
| TAAQAQTGPEEDSGS | 856 | Q13428 | |
| PASQKDSGAASEQAT | 676 | Q9BU23 | |
| EGDPTNGSGEQSKTS | 46 | Q9NSI8 | |
| NKETKQGETPGASSD | 2411 | P25391 | |
| PASETQAQDSGEVTG | 131 | Q9ULN7 | |
| KEAGNQPQSSDGTTS | 61 | Q9Y2B9 | |
| SGGQPADTQTRATSK | 96 | Q9Y448 | |
| KLPGQDESTAGTSEQ | 196 | Q9Y520 | |
| GSAPSSEGAKNGQES | 2031 | Q9Y520 | |
| STNTGTVPGSEKDSD | 281 | Q99460 | |
| ESKPSVDSGTLEDNT | 351 | Q96EA4 | |
| QVGSSKDQGSASPVS | 201 | Q5T8A7 | |
| KDQGSASPVSVSSDD | 206 | Q5T8A7 | |
| AEHSNTTEGPTGKQE | 46 | Q86XR7 | |
| QKDQSSDATPGPASS | 351 | Q9P1W8 | |
| GATGPEEQSDSLKSV | 481 | Q96J65 | |
| QNQSDDGDTETSPTK | 846 | Q13972 | |
| TGKRPNENSSADISG | 471 | Q8NEG4 | |
| AGKEESGVSVSNSQP | 261 | Q99808 | |
| KTNGAENETPSSGNT | 366 | Q86UE8 | |
| ENETPSSGNTELKDT | 371 | Q86UE8 | |
| ASEEGQNGSSPKSKT | 456 | P35611 | |
| TPSGSSSGNNRIEDK | 251 | Q6ZVT6 | |
| DTSGNTEGSPAAEKA | 501 | Q96S66 | |
| QLKSEAAGSPDQGST | 516 | Q96S66 | |
| EDTCKSGPSTNTQSG | 346 | Q15583 | |
| EAGVATGSEAQSSPQ | 181 | Q63HN8 | |
| QTPKDSTGKSGAEAQ | 131 | O43493 | |
| STGKSGAEAQTPEDS | 136 | O43493 | |
| GGASNNSETSEEPKI | 906 | Q15468 | |
| GENGSQRPVTVDSSK | 211 | Q8NHH1 | |
| SGSASTPQEEQTKEG | 86 | O94966 | |
| QSDKEPGITASATDT | 141 | Q9H0M4 | |
| PGSEIATSEKSGEQG | 1026 | Q76I76 | |
| ELGNTSSSEGEKDSP | 1546 | Q92545 | |
| GQLGEKQLPSSTSDD | 336 | Q8N554 | |
| NAGSSKEEAGETSPA | 636 | Q9UKY1 | |
| SSRQVSEDGQPKGVS | 1261 | P53804 | |
| PSEQKDSEQGSGQSK | 1721 | Q5JSZ5 | |
| SSSDDEGAAQNSTKP | 296 | P08240 | |
| SQDPKQGTSGGVDTS | 1381 | O95359 | |
| EPAGSQETKDSGSQE | 441 | Q9BVJ6 | |
| QECETEVSPSQTGGS | 1281 | Q12888 | |
| TAPEVGSNSQDGDAT | 51 | A8MZF0 | |
| ISSQSSDPKDASGDG | 431 | Q92994 | |
| SEENEITQPGGSSAK | 16 | Q9HC78 | |
| KEQSGSSNGSESSPA | 2576 | Q9UPU5 | |
| DVTKINETQGSPGAS | 106 | Q5T619 | |
| SSTSPQKAEEGGRQS | 106 | P35711 | |
| SAGEISKQAPDTSDG | 186 | Q6ZSB9 | |
| QKEAAGSSGTVPTQD | 661 | Q5JPB2 | |
| GVGQANKPDETSKTS | 1366 | Q14966 | |
| SQSKTGDECGDSPDV | 71 | Q8WWM1 | |
| DKQSPTGSDSGSVQE | 1501 | Q15911 | |
| KGGSEGQPESSTASN | 376 | Q9P206 |